These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 1599915

  • 1. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
    MacLean GD, Bowen-Yacyshyn MB, Samuel J, Meikle A, Stuart G, Nation J, Poppema S, Jerry M, Koganty R, Wong T.
    J Immunother (1991); 1992 May; 11(4):292-305. PubMed ID: 1599915
    [Abstract] [Full Text] [Related]

  • 2. Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer.
    Slovin SF, Ragupathi G, Musselli C, Fernandez C, Diani M, Verbel D, Danishefsky S, Livingston P, Scher HI.
    Cancer Immunol Immunother; 2005 Jul; 54(7):694-702. PubMed ID: 15726361
    [Abstract] [Full Text] [Related]

  • 3. Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant.
    Longenecker BM, Reddish M, Koganty R, MacLean GD.
    Ann N Y Acad Sci; 1993 Aug 12; 690():276-91. PubMed ID: 7690215
    [Abstract] [Full Text] [Related]

  • 4. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.
    Longenecker BM, Reddish M, Koganty R, MacLean GD.
    Adv Exp Med Biol; 1994 Aug 12; 353():105-24. PubMed ID: 7527178
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients.
    Adluri S, Helling F, Ogata S, Zhang S, Itzkowitz SH, Lloyd KO, Livingston PO.
    Cancer Immunol Immunother; 1995 Sep 12; 41(3):185-92. PubMed ID: 7553688
    [Abstract] [Full Text] [Related]

  • 6. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine.
    MacLean GD, Reddish MA, Koganty RR, Longenecker BM.
    J Immunother Emphasis Tumor Immunol; 1996 Jan 12; 19(1):59-68. PubMed ID: 8859725
    [Abstract] [Full Text] [Related]

  • 7. Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant.
    MacLean GD, Reddish M, Koganty RR, Wong T, Gandhi S, Smolenski M, Samuel J, Nabholtz JM, Longenecker BM.
    Cancer Immunol Immunother; 1993 Jan 12; 36(4):215-22. PubMed ID: 8439984
    [Abstract] [Full Text] [Related]

  • 8. A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer.
    Miles DW, Towlson KE, Graham R, Reddish M, Longenecker BM, Taylor-Papadimitriou J, Rubens RD.
    Br J Cancer; 1996 Oct 12; 74(8):1292-6. PubMed ID: 8883420
    [Abstract] [Full Text] [Related]

  • 9. Influence of terminal residue on adjacent disaccharide immunogenicity.
    Irazoqui FJ, Lopez PH, Mandel U, Nores GA.
    Mol Immunol; 2002 Mar 12; 38(11):825-31. PubMed ID: 11922940
    [Abstract] [Full Text] [Related]

  • 10. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
    Ragupathi G, Deshpande PP, Coltart DM, Kim HM, Williams LJ, Danishefsky SJ, Livingston PO.
    Int J Cancer; 2002 May 10; 99(2):207-12. PubMed ID: 11979435
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers.
    Longenecker BM, Willans DJ, MacLean GD, Selvaraj S, Suresh MR, Noujaim AA.
    J Natl Cancer Inst; 1987 Mar 10; 78(3):489-96. PubMed ID: 3469463
    [Abstract] [Full Text] [Related]

  • 12. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.
    Ragupathi G, Koide F, Sathyan N, Kagan E, Spassova M, Bornmann W, Gregor P, Reis CA, Clausen H, Danishefsky SJ, Livingston PO.
    Cancer Immunol Immunother; 2003 Oct 10; 52(10):608-16. PubMed ID: 12811527
    [Abstract] [Full Text] [Related]

  • 13. Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccine.
    Sandmaier BM, Oparin DV, Holmberg LA, Reddish MA, MacLean GD, Longenecker BM.
    J Immunother; 1999 Jan 10; 22(1):54-66. PubMed ID: 9924700
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines.
    Kim SK, Ragupathi G, Musselli C, Choi SJ, Park YS, Livingston PO.
    Vaccine; 1999 Nov 12; 18(7-8):597-603. PubMed ID: 10547417
    [Abstract] [Full Text] [Related]

  • 15. IgG immune response to tumor-associated carbohydrate antigens (TF, Tn, alphaGal) in patients with breast cancer: impact of neoadjuvant chemotherapy and relation to the survival.
    Kurtenkov O, Klaamas K, Rittenhouse-Olson K, Vahter L, Sergejev B, Miljukhina L, Shljapnikova L.
    Exp Oncol; 2005 Jun 12; 27(2):136-40. PubMed ID: 15995632
    [Abstract] [Full Text] [Related]

  • 16. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
    Campbell BJ, Finnie IA, Hounsell EF, Rhodes JM.
    J Clin Invest; 1995 Feb 12; 95(2):571-6. PubMed ID: 7860740
    [Abstract] [Full Text] [Related]

  • 17. Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines.
    Ragupathi G, Cappello S, Yi SS, Canter D, Spassova M, Bornmann WG, Danishefsky SJ, Livingston PO.
    Vaccine; 2002 Jan 15; 20(7-8):1030-8. PubMed ID: 11803062
    [Abstract] [Full Text] [Related]

  • 18. Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).
    Fung PY, Longenecker BM.
    Cancer Res; 1991 Feb 15; 51(4):1170-6. PubMed ID: 1825477
    [Abstract] [Full Text] [Related]

  • 19. Analysis of human tumor associated Thomsen-Friedenreich antigen.
    Samuel J, Noujaim AA, MacLean GD, Suresh MR, Longenecker BM.
    Cancer Res; 1990 Aug 01; 50(15):4801-8. PubMed ID: 2196117
    [Abstract] [Full Text] [Related]

  • 20. Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci.
    Krug LM, Ragupathi G, Hood C, George C, Hong F, Shen R, Abrey L, Jennings HJ, Kris MG, Livingston PO.
    Cancer Immunol Immunother; 2012 Jan 01; 61(1):9-18. PubMed ID: 21811785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.